DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 82 filers reported holding DICE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $707,214 | -59.7% | 15,222 | -75.1% | 0.00% | -100.0% |
| Q1 2023 | $1,753,638 | +1.7% | 61,209 | +10.7% | 0.00% | 0.0% |
| Q4 2022 | $1,723,974 | +64.4% | 55,309 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $1,048,806 | +28.4% | 53,011 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $817,136 | -10.9% | 53,295 | +12.0% | 0.00% | 0.0% |
| Q1 2022 | $917,444 | – | 47,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $102,737,575 | 55.73% |
| Sands Capital Ventures, LLC | 2,748,970 | $85,768 | 23.49% |
| OUP Management Co., LLC | 268,346 | $8,372,395 | 13.67% |
| New Leaf Venture Partners, L.L.C. | 371,693 | $11,596,822 | 8.40% |
| RA Capital Management | 6,848,911 | $213,686,023 | 4.33% |
| VR Adviser, LLC | 819,000 | $25,552,800 | 4.30% |
| SVB FINANCIAL GROUP | 42,358 | $1,321,570 | 3.61% |
| Logos Global Management LP | 660,000 | $20,592,000 | 2.41% |
| Deep Track Capital, LP | 1,734,143 | $54,105,262 | 2.27% |
| Samsara BioCapital, LLC | 202,773 | $6,326,518 | 1.36% |